Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 10028-24-7
2. Sodium Phosphate Dibasic Dihydrate
3. Disodium Hydrogen Phosphate Dihydrate
4. Sodium Hydrogenphosphate Dihydrate
5. Phosphoric Acid, Disodium Salt, Dihydrate
6. Di-sodium Hydrogen Phosphate Dihydrate
7. Sodium Phosphate, Dibasic, Dihydrate
8. Disodium;hydrogen Phosphate;dihydrate
9. Phosphoric Acid, Disodium Salt, Dihydrate (8ci,9ci)
10. 94255i6e2t
11. Disodium Hydrogenphosphate Dihydrate
12. Mfcd00149182
13. Unii-94255i6e2t
14. Sodiumhydrogenphosphatedihydrate
15. Dibasic Dihydratesodium Phosphate
16. Chembl2107560
17. Disodium Orthophosphate Dihydrate
18. Dtxsid1074250
19. Chebi:91258
20. Sodium Hydrogen Phosphate Dihydrate
21. Disodium Phosphate, Dihydrate
22. Sodium Monohydrogen Phosphate Dihydrat
23. Akos015913903
24. Akos028109191
25. Sodium Hydrogen Orthophosphate Dihydrate
26. Sodium Hydrogen Phosphate--water (1/2)
27. Sodium Phosphate, Dibasic Dihydrate
28. Ft-0625317
29. Sodium Phosphate Dibasic Dihydrate, Lr, >=98%
30. Sodium Phosphate, Dibasic Dihydrate [mi]
31. Disodium Phosphate Dihydrate [ep Monograph]
32. Sodium Phosphate Dibasic Dihydrate, P.a., 99.0%
33. Sodium Phosphate, Dibasic, Dihydrate [ii]
34. Sodium Phosphate Dibasic Dihydrate [who-dd]
35. Q27163166
36. Sodium Phosphate Dibasic Dihydrate, Bioultra, >=99.0% (t)
37. Sodium Phosphate Dibasic Dihydrate, Purum P.a., >=98.0% (t)
38. Sodium Phosphate Dibasic Dihydrate, Tested According To Ph.eur.
39. Sodium Phosphate Dibasic Dihydrate, Vetec(tm) Reagent Grade, 98%
40. Sodium Phosphate Dibasic Dihydrate, Bioultra, For Molecular Biology, >=99.0% (t)
41. Sodium Phosphate Dibasic Dihydrate, Puriss. P.a., Buffer Substance, >=99.5%
42. Sodium Phosphate Dibasic Dihydrate, Meets Analytical Specification Of Ph.??eur., Bp, 98.5-101% (calc. To The Dried Substance)
43. Sodium Phosphate Dibasic Dihydrate, Pharmagrade, Usp, Manufactured Under Appropriate Gmp Controls For Pharma Or Biopharmaceutical Production.
44. Sodium Phosphate Dibasic Dihydrate, Puriss. P.a., Reag. Ph. Eur., 98.5-101.0% (calc. To The Dried Substance)
Molecular Weight | 177.99 g/mol |
---|---|
Molecular Formula | H5Na2O6P |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 0 |
Exact Mass | 177.96191344 g/mol |
Monoisotopic Mass | 177.96191344 g/mol |
Topological Polar Surface Area | 85.4 Ų |
Heavy Atom Count | 9 |
Formal Charge | 0 |
Complexity | 46.5 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 5 |
Related Excipient Companies
Excipients by Applications
Market Place
Reply
17 Oct 2024
Reply
15 Oct 2022
Reply
27 Aug 2022
ABOUT THIS PAGE
A Sodium phosphate, dibasic, heptahydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium phosphate, dibasic, heptahydrate, including repackagers and relabelers. The FDA regulates Sodium phosphate, dibasic, heptahydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium phosphate, dibasic, heptahydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sodium phosphate, dibasic, heptahydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sodium phosphate, dibasic, heptahydrate supplier is an individual or a company that provides Sodium phosphate, dibasic, heptahydrate active pharmaceutical ingredient (API) or Sodium phosphate, dibasic, heptahydrate finished formulations upon request. The Sodium phosphate, dibasic, heptahydrate suppliers may include Sodium phosphate, dibasic, heptahydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium phosphate, dibasic, heptahydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium phosphate, dibasic, heptahydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium phosphate, dibasic, heptahydrate active pharmaceutical ingredient (API) in detail. Different forms of Sodium phosphate, dibasic, heptahydrate DMFs exist exist since differing nations have different regulations, such as Sodium phosphate, dibasic, heptahydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium phosphate, dibasic, heptahydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium phosphate, dibasic, heptahydrate USDMF includes data on Sodium phosphate, dibasic, heptahydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium phosphate, dibasic, heptahydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium phosphate, dibasic, heptahydrate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sodium phosphate, dibasic, heptahydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sodium phosphate, dibasic, heptahydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sodium phosphate, dibasic, heptahydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sodium phosphate, dibasic, heptahydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sodium phosphate, dibasic, heptahydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sodium phosphate, dibasic, heptahydrate suppliers with NDC on PharmaCompass.
Sodium phosphate, dibasic, heptahydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium phosphate, dibasic, heptahydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium phosphate, dibasic, heptahydrate GMP manufacturer or Sodium phosphate, dibasic, heptahydrate GMP API supplier for your needs.
A Sodium phosphate, dibasic, heptahydrate CoA (Certificate of Analysis) is a formal document that attests to Sodium phosphate, dibasic, heptahydrate's compliance with Sodium phosphate, dibasic, heptahydrate specifications and serves as a tool for batch-level quality control.
Sodium phosphate, dibasic, heptahydrate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium phosphate, dibasic, heptahydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium phosphate, dibasic, heptahydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium phosphate, dibasic, heptahydrate EP), Sodium phosphate, dibasic, heptahydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium phosphate, dibasic, heptahydrate USP).
LOOKING FOR A SUPPLIER?